Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

I came across a TikTok promoting this and decided to take a chance since the price was super reasonable. My eyes looked ...

For the almost 520,000 Americans who will undergo treatment this year, the process leaves little room for a full life. An ...

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Mucus presents a formidable barrier to nanoparticle drug-delivery systems, but adding a coating of polymer molecules helps ... This could include treatment of diseases such as cancer and ...

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of ...

Casey Means, MD, author of “Good Energy,” discovered that the pathway to optimal health starts with your fork. Read an ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?